Stroke Trial, Recruiting NCT03857529 Sponsor: MetroHealth Medical Center Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT03857529
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 21 or older
  • People who had their first stroke (either a bleeding stroke or a blockage stroke) at least 6 months ago
  • People who are able to follow a simple 3-step instruction and remember 2 out of 3 items after a 30-minute delay
  • People who have full movement of their unaffected arm, including bending and straightening the elbow and fully opening and closing the hand
  • People who have enough movement in their affected shoulder and elbow to place their affected hand on a table for task practice
  • People who are able to sit without support in a straight-backed chair without armrests for the duration of the initial assessment
  • People who are medically stable
  • People who can extend (straighten) their fingers at least 10 degrees on the affected side
  • People who have weakness on one side affecting the arm and hand, with finger strength rated no higher than 4 out of 5 on a standard muscle test, and a specific hand movement score within a set range on a standard stroke assessment tool (confirm with trial site)
  • People whose skin is unbroken and intact on the affected arm, hand, and scalp
  • People whose finger and thumb muscles respond to gentle electrical stimulation on the skin by producing a useful degree of hand opening, without causing pain
  • People without significant problems with vision or hearing

Who may not be able to join:

  • People who have a neurological condition other than stroke that also affects the weaker arm — for example, nerve injury, Parkinson's disease, spinal cord injury, brain injury from trauma, or multiple sclerosis
  • People who have a seizure disorder that is not well controlled
  • People who are currently taking certain medications that lower the seizure threshold, as determined by the study doctor
  • People who have a cardiac pacemaker, another implanted electronic device, or a stent
  • People who are pregnant
  • People who have received botox injections into any muscle of either arm in the last 3 months
  • People who have no feeling in the affected arm, forearm, or hand
  • People with severely impaired thinking or communication abilities
  • People with a condition called uncompensated hemi-neglect, where the brain does not properly register sensations on one side of the body (confirm with trial site)
  • People who have severe pain in the shoulder or hand that prevents placing the hand in the workspace
  • People who have a metal implant in the head

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: David A Cunningham, PhD, MetroHealth Medical Center

Phone: (216) 957-3349

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
MetroHealth Medical Center
Registry
ClinicalTrials.gov
Start date
1 August 2019
Est. completion
1 August 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Corticospinal Excitability; Reaction Time

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov